TipRanks
Go Ultimate55% OFF

HLS Therapeutics Inc (74D) Revenue

HLS Therapeutics Inc Revenue

HLS Therapeutics Inc had a revenue of 14.29M in the quarter ending Jun 30, 2026, with 12.97%. This bring the company's revenue in the last twelve months to 55.89M, Increased 0.22%. In the fiscal year ending Dec 31, 2025, HLS Therapeutics Inc had annual revenue of 56.47M with -0.26% growth.

Revenue (ttm)
55.89M
Revenue Growth
-7.05%
P/S Ratio
1.58
Revenue/Employee
EUR 664,371
Employees
85
Market Cap
EUR 89.09M

Revenue Chart

HLS Therapeutics Inc Revenue - Annual

020M40M60M80M75.08M61.41M54.16M56.11M60.01M61.47M63.07M56.62M56.47M201720182019202020212022202320242025
Revenue History
Download to Excel
DE:74D revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202556.47M-147.44K-0.26%
Dec 31, 202456.62M-6.46M-10.23%
Dec 31, 202363.07M1.61M2.61%
Dec 31, 202261.47M1.46M2.43%
Dec 31, 202160.01M3.90M6.95%
Dec 31, 202056.11M1.95M3.60%
Dec 31, 201954.16M-7.25M-11.81%
Dec 31, 201861.41M-13.67M-18.20%
Dec 31, 201775.08M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:74D55.89M
TSE:GUD547.30M
TSE:CPH49.29M
TSE:AQS815.03K
TSE:MDP103.30M
TSE:RX55.67M